Lead – Business Operations, Global Oncology

Role Overview/Purpose

The Lead – Business Operations, Global Oncology will play a critical role in driving launch excellence and early access strategies across small to mid‑sized markets where Glenmark Oncology does not have dedicated in‑country oncology leadership. This role will act as a strategic and operational partner to the Head of Global Commercial Oncology, ensuring organizational readiness, optimal resource allocation, and execution of commercial infrastructure (including CRM and analytics).

The incumbent will also serve as support to the Global Head in governance, decision‑making, and cross‑functional alignment.

• Launch Excellence & Early Access Strategy
• Lead the development and execution of launch strategies for oncology assets in small‑to‑mid‑sized markets.
• Design scalable, repeatable “go‑to‑market” models tailored for distributor‑led or hybrid markets.
• Drive early access strategies including:
• Named Patient Programs (NPPs)
• Compassionate use programs
• Managed access agreements
• Collaborate with Medical, Market Access, Regulatory, and Supply teams to ensure timely market entry.
• Develop launch readiness frameworks, KPIs, and tracking mechanisms.
• Market Development (Non‑Core / White Space Markets)
• Identify, prioritize, and assess new market opportunities where Glenmark lacks oncology presence.
• Build market entry playbooks (partner vs. direct vs. hybrid models).
• Support distributor selection, onboarding, and performance management.
• Ensure alignment of local execution with global brand strategy.
• Commercial Operations & Infrastructure
• Lead implementation and optimization of CRM systems (e.g., Veeva, Salesforce Health Cloud).
• Establish standardized commercial processes, reporting dashboards, and performance tracking.
• Drive data‑driven decision‑making through analytics and insights generation.
• Oversee commercial excellence initiatives including:
• Sales force effectiveness (where applicable)
• Omnichannel engagement frameworks
• Digital enablement tools
• Organizational Readiness & Capability Building
• Partner with the Head of Global Commercial Oncology to ensure readiness for upcoming launches.
• Define target operating models for new markets.
• Support hiring strategy, role design, and capability frameworks (especially for distributor markets).
• Develop training frameworks and onboarding programs for new teams/partners.
• Resource Allocation & Financial Planning
• Lead commercial budgeting and resource allocation across emerging markets.
• Optimize deployment of financial and human resources based on market potential and strategic priority.
• Track ROI on launch investments and commercial initiatives.
• Support long‑range planning (LRP) and annual operating plans (AOP).
• Strategic Planning & Governance
• Act as a strategic advisor and deputy to the Head of Global Commercial Oncology.
• Support development of global oncology commercial strategy.
• Lead cross‑functional governance forums and business reviews.
• Drive alignment across global, regional, and local stakeholders.
• Cross‑Functional Leadership
• Serve as a central coordination point across:
  Medical Affairs, Market Access, Regulatory, Supply Chain, Finance
• Ensure integrated execution of launch and commercialization plans.
• Competitive Intelligence & Market Insights
• Monitor competitive landscape across oncology markets.
• Benchmark best practices from leading oncology players (MNCs).
• Translate insights into actionable strategies for Glenmark.
• Compliance & Risk Management
• Ensure all commercial activities adhere to global compliance standards and local regulations.
• Identify and mitigate risks related to distributor‑led markets and early access programs.
• Key Deliverables / Success Metrics
• Successful launch of oncology assets in priority emerging markets.
• Time‑to‑market reduction in non‑core geographies.
• CRM implementation effectiveness and adoption rates.
• Achievement of early access program targets.
• Budget adherence and ROI optimization.
• Distributor performance and market expansion outcomes.

• Oncology KOLs and treatment centers
• Oncology societies and networks
• Strategic partners and service providers

• Regional/Country Commercial…